Harbor Investment Advisory LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 18.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 698 shares of the financial services provider's stock after selling 154 shares during the quarter. Harbor Investment Advisory LLC's holdings in CME Group were worth $143,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. Parkside Financial Bank & Trust grew its holdings in shares of CME Group by 15.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 371 shares of the financial services provider's stock valued at $85,000 after purchasing an additional 51 shares during the last quarter. Tiedemann Advisors LLC boosted its position in shares of CME Group by 0.3% during the first quarter. Tiedemann Advisors LLC now owns 19,681 shares of the financial services provider's stock worth $4,682,000 after buying an additional 53 shares during the period. MJP Associates Inc. ADV boosted its position in shares of CME Group by 5.7% during the second quarter. MJP Associates Inc. ADV now owns 983 shares of the financial services provider's stock worth $201,000 after buying an additional 53 shares during the period. Insight Folios Inc boosted its position in shares of CME Group by 2.6% during the second quarter. Insight Folios Inc now owns 2,148 shares of the financial services provider's stock worth $440,000 after buying an additional 55 shares during the period. Finally, KC Investment Advisors LLC boosted its position in shares of CME Group by 1.7% during the first quarter. KC Investment Advisors LLC now owns 3,343 shares of the financial services provider's stock worth $795,000 after buying an additional 55 shares during the period. 85.56% of the stock is owned by institutional investors.
Get
CME Group alerts:
Insider Buying and Selling at CME Group
In other CME Group news, insider Hilda Harris Piell sold 4,901 shares of the business's stock in a transaction on Monday, August 15th. The shares were sold at an average price of $203.88, for a total transaction of $999,215.88. Following the sale, the insider now directly owns 33,140 shares of the company's stock, valued at approximately $6,756,583.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Daniel R. Glickman sold 500 shares of the company's stock in a transaction on Wednesday, August 31st. The shares were sold at an average price of $196.39, for a total value of $98,195.00. Following the transaction, the director now directly owns 14,597 shares of the company's stock, valued at $2,866,704.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 4,901 shares of the company's stock in a transaction on Monday, August 15th. The stock was sold at an average price of $203.88, for a total transaction of $999,215.88. Following the completion of the transaction, the insider now directly owns 33,140 shares in the company, valued at $6,756,583.20. The disclosure for this sale can be found here. Insiders have sold a total of 10,511 shares of company stock valued at $2,123,186 in the last three months. 0.30% of the stock is currently owned by company insiders.
CME Group Price Performance
Shares of NASDAQ:CME opened at $179.98 on Tuesday. CME Group Inc. has a one year low of $177.87 and a one year high of $256.94. The stock has a fifty day moving average of $197.68 and a 200-day moving average of $209.63. The company has a market capitalization of $64.69 billion, a PE ratio of 22.33, a price-to-earnings-growth ratio of 2.92 and a beta of 0.40. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The financial services provider reported $1.97 EPS for the quarter, beating analysts' consensus estimates of $1.92 by $0.05. CME Group had a return on equity of 9.65% and a net margin of 60.43%. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same quarter in the prior year, the firm earned $1.64 EPS. The company's quarterly revenue was up 4.9% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 7.96 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Friday, September 9th will be paid a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Thursday, September 8th. CME Group's dividend payout ratio (DPR) is currently 49.63%.
Analyst Ratings Changes
CME has been the subject of several analyst reports. Jefferies Financial Group initiated coverage on CME Group in a research report on Tuesday, May 31st. They set a "buy" rating and a $267.00 price objective for the company. Raymond James downgraded CME Group from an "outperform" rating to a "market perform" rating in a research report on Monday, August 15th. Deutsche Bank Aktiengesellschaft boosted their price objective on CME Group from $208.00 to $212.00 and gave the stock a "hold" rating in a research report on Friday, August 12th. UBS Group reduced their price objective on CME Group from $246.00 to $240.00 and set a "buy" rating for the company in a research report on Tuesday, August 2nd. Finally, Morgan Stanley cut their target price on CME Group from $242.00 to $226.00 and set an "equal weight" rating for the company in a research report on Thursday, July 28th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $230.80.
CME Group Company Profile
(Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Featured Articles
- Get a free copy of the StockNews.com research report on CME Group (CME)
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- MO Money: Why Altria Group Stock is Rallying
- Is the Market Overreacting with Shopify Stock?
- Fed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Three Consumer Stocks That Could Outperform In Q4
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
